Bio Break: Groundbreaking Discoveries in Infectious Disease
In this episode of Bio Break, Nick shares one of his favorite discoveries in the world of infectious disease research — the groundbreaking discovery of Helicobacter pylori and its role in causing peptic ulcers. This fascinating story showcases how persistence, scientific curiosity, and innovative thinking can lead to discoveries that reshape medical science.
The discovery of Helicobacter pylori dates back to the 1980s, when Australian physicians Barry Marshall and Robin Warren suspected that stomach ulcers were not caused by stress or spicy foods, as commonly believed, but by a bacterium. Through determination and clever research, they identified Helicobacter pylori — a gram-negative, spiral-shaped bacterium — as the culprit. Their discovery wasn’t without challenges. Early laboratory cultures of patient swabs yielded no growth, as H. pylori requires low-oxygen environments and longer incubation periods to grow. It was only after a fortunate weekend delay that colonies finally appeared, changing the course of the study.
Nick recounts how, to prove their theory, Barry Marshall famously ingested a pure culture of H. pylori. This led to him developing gastritis and an ulcer, definitively proving the bacteria’s role. Thankfully, he treated the infection with antibiotics, validating the hypothesis and demonstrating that ulcers could be cured through antimicrobial therapy rather than solely through lifestyle changes.
This discovery revolutionized gastroenterology and earned Marshall and Warren the Nobel Prize in Physiology or Medicine in 2005. In this video, Nick and Joris highlight not only the scientific process behind the discovery but also the risks and innovation that make research in infectious diseases so exciting.
If you’re fascinated by microbiology, medical device development, and real-world medical breakthroughs, this story of discovery is one you won’t want to miss.
For Startups or Founders developing a device that incorporates novel technology or is like nothing else, the FDA breakthrough medical device program may be the best regulatory option. Learn more.
Related Resources
This article traces the Pennes bioheat equation from its 1948 origins to modern multiscale approaches, explaining how engineers select the right level of modelling complexity across device categories.
Five methods for building accurate project estimates, from gut feel to bottom-up, plus three add-ons that sharpen any estimate.
Designers and engineers today have no shortage of tools to improve designs, accelerate timelines, and meet cost targets. The challenge is knowing what to use and when.
Nick and Nigel breaks down what actually goes into the cost of getting a sterilized device into a user’s hands, and why up to 30% of costs can sit in places most teams don’t plan for.